Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H19FN2O6S |
Molecular Weight | 410.417 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ONC(=O)C1(CCOCC1)NS(=O)(=O)C2=CC=C(OC3=CC=C(F)C=C3)C=C2
InChI
InChIKey=ZBRHTUMWSDPCMI-UHFFFAOYSA-N
InChI=1S/C18H19FN2O6S/c19-13-1-3-14(4-2-13)27-15-5-7-16(8-6-15)28(24,25)21-18(17(22)20-23)9-11-26-12-10-18/h1-8,21,23H,9-12H2,(H,20,22)
Molecular Formula | C18H19FN2O6S |
Molecular Weight | 410.417 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:52:33 GMT 2023
by
admin
on
Fri Dec 15 15:52:33 GMT 2023
|
Record UNII |
516DO4KL5R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
516DO4KL5R
Created by
admin on Fri Dec 15 15:52:33 GMT 2023 , Edited by admin on Fri Dec 15 15:52:33 GMT 2023
|
PRIMARY | |||
|
DTXSID8047266
Created by
admin on Fri Dec 15 15:52:33 GMT 2023 , Edited by admin on Fri Dec 15 15:52:33 GMT 2023
|
PRIMARY | |||
|
230954-09-3
Created by
admin on Fri Dec 15 15:52:33 GMT 2023 , Edited by admin on Fri Dec 15 15:52:33 GMT 2023
|
PRIMARY | |||
|
9866250
Created by
admin on Fri Dec 15 15:52:33 GMT 2023 , Edited by admin on Fri Dec 15 15:52:33 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
PARENT -> METABOLITE |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||